| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/17/2001 | WO2001034646A2 Recombinant gelatins |
| 05/17/2001 | WO2001034617A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | WO2001034574A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 05/17/2001 | WO2001034549A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 05/17/2001 | WO2001034192A2 Improved method of immunization |
| 05/17/2001 | WO2001034185A2 Induction of mucosal immunity by vaccination via the skin route |
| 05/17/2001 | WO2001034174A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | WO2001034168A1 Inhibition of pathogens by bacillus coagulans strains |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2001034165A1 Therapeutic compositions and methods of use thereof |
| 05/17/2001 | WO2001034152A1 Nasal drops containing fused pyridazine derivatives |
| 05/17/2001 | WO2001034148A1 Solid preparations for oral use |
| 05/17/2001 | WO2001034147A1 Oral solid preparation |
| 05/17/2001 | WO2001034144A1 Lipoxin a4 and its analogs for the treatment of dry eye |
| 05/17/2001 | WO2001034140A1 Pharmaceutical formulation |
| 05/17/2001 | WO2001034139A1 Pharmaceutical formulation containing tolterodine and its use |
| 05/17/2001 | WO2001034131A2 Combination chemotherapy |
| 05/17/2001 | WO2001034130A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 05/17/2001 | WO2001034123A1 Hmg-coa reductase inhibitor extended release formulation |
| 05/17/2001 | WO2001034122A1 Film coating method for tablets |
| 05/17/2001 | WO2001034121A2 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 05/17/2001 | WO2001034120A1 Apparatus and method for preparing microparticles using in-line solvent extraction |
| 05/17/2001 | WO2001034119A2 Inhibitors of crystallization in a solid dispersion |
| 05/17/2001 | WO2001034118A2 Solid dispersion pharmaceutical formulations |
| 05/17/2001 | WO2001034117A1 A method for chemoprevention of prostate cancer |
| 05/17/2001 | WO2001034116A2 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 05/17/2001 | WO2001034115A2 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 05/17/2001 | WO2001034114A1 Liquid heparin formulation |
| 05/17/2001 | WO2001034113A2 Apparatus and method for preparing microparticles |
| 05/17/2001 | WO2001034112A1 Sustained-release drug formulations for implantation |
| 05/17/2001 | WO2001022992A3 Influenza vaccine |
| 05/17/2001 | WO2001019183A3 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 05/17/2001 | WO2001016220A8 Method of producing an absorbent foam material |
| 05/17/2001 | WO2001003648A3 Oregano-based therapeutic composition |
| 05/17/2001 | WO2000071108A3 Methods for treatment of asthma using s-oxybutynin |
| 05/17/2001 | WO1999048536A3 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 05/17/2001 | WO1999040883A3 Compositions and methods for the treatment of cystic fibrosis |
| 05/17/2001 | US20010001280 Dosage form comprising liquid formulation |
| 05/17/2001 | US20010001279 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 05/17/2001 | DE19955836C1 Ophthalmologisches Implantat Ophthalmologic implant |
| 05/17/2001 | DE19954923A1 Stable, purified powder containing normally liquid active agent, e.g. oil or drug, obtained by forming solid containing active agent and carrier then extracting adherent liquid active agent with solvent |
| 05/17/2001 | DE19954843A1 Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung A process for the encapsulation of proteins or peptides in liposomes, liposomes produced by the method and the use thereof |
| 05/17/2001 | DE19954528A1 Eingekapseltes Aroma The encapsulated flavor |
| 05/17/2001 | DE19954516A1 Epinastin-haltige Lösungen Epinastine-containing solutions |
| 05/17/2001 | DE19952982A1 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 05/17/2001 | DE19943496C1 Direkt verpressbarer Rohstoff für Komprimate Directly compressible material for compressed |
| 05/17/2001 | DE10044129A1 New autogenous vaccine useful in the treatment of autoimmune and allergic diseases |
| 05/17/2001 | CA2391299A1 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | CA2391278A1 Therapeutic compositions and methods of use thereof |
| 05/17/2001 | CA2391243A1 Microcrystalline cellulose cushioning granules |
| 05/17/2001 | CA2390999A1 Induction of mucosal immunity by vaccination via the skin route |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390919A1 Nose drop containing condensed pyridazine |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390557A1 Solid preparations for oral use |
| 05/17/2001 | CA2390553A1 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 05/17/2001 | CA2390301A1 Hmg-coa reductase inhibitor extended release formulation |
| 05/17/2001 | CA2390132A1 Film coating method for tablets |
| 05/17/2001 | CA2390128A1 Pharmaceutical formulation |
| 05/17/2001 | CA2389982A1 Inhibition of pathogens by bacillus coagulans strains |
| 05/17/2001 | CA2388918A1 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388044A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 05/17/2001 | CA2386878A1 Lipoxin a4 and its analogs for the treatment of dry eye |
| 05/17/2001 | CA2386876A1 Combination chemotherapy |
| 05/16/2001 | EP1099709A1 Low-substituted hydroxypropyl cellulose and process for manufacturing the same |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1099434A1 Nonwoven material comprising an adhesive and apertures |
| 05/16/2001 | EP1099385A2 Encapsulated flavour |
| 05/16/2001 | EP1098959A2 Medium and matrix for long-term proliferation of cells |
| 05/16/2001 | EP1098935A1 Coating and excipient agent for oral or dermal dosage forms |
| 05/16/2001 | EP1098931A1 Polyionic hydrogels based on xanthan and chitosan for stabilising and controlled release of vitamins |
| 05/16/2001 | EP1098696A1 Polyelectrolyte coverings on biological templates |
| 05/16/2001 | EP1098663A1 Slow release formulations comprising anionic polysaccharide |
| 05/16/2001 | EP1098660A1 Encapsulation of water soluble peptides |
| 05/16/2001 | EP1098654A1 Antilipemic composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098651A2 Novel urokinase inhibitors |
| 05/16/2001 | EP1098649A1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 05/16/2001 | EP1098646A1 Stabilized carvedilol injection solution |
| 05/16/2001 | EP1098643A2 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 05/16/2001 | EP1098640A1 Anti-ulcer composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098637A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 05/16/2001 | EP1098636A1 A wet granulation method for preparing a stable pharmaceutical formulation |
| 05/16/2001 | EP1098635A1 Enteric coated pharmaceutical tablet and method of manufacturing |
| 05/16/2001 | EP1098634A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 05/16/2001 | EP1098633A1 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
| 05/16/2001 | EP1098631A1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/16/2001 | EP1098628A1 Casein formulations for the delivery of bioactive constituents |
| 05/16/2001 | EP1098610A1 Biodegradable compositions for the controlled release of encapsulated substances |
| 05/16/2001 | EP1011647A4 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 05/16/2001 | EP0996437B1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 05/16/2001 | EP0982990A4 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 05/16/2001 | EP0941089B1 Use of anti-microtubule agents for treating or preventing multiple sclerosis |
| 05/16/2001 | EP0812411B1 Freeze-drying process and apparatus |
| 05/16/2001 | EP0809489B1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof |
| 05/16/2001 | CN2430160Y Thermal application plaster for removing obstruction in channels to release pain |
| 05/16/2001 | CN1295484A Formulations for protection of PEG-interferon alpha conjugates |
| 05/16/2001 | CN1295483A Gelling ophthalmic composition containing xanthan gum |
| 05/16/2001 | CN1295478A Novel galanic formulation of meloxicam for oral administration |
| 05/16/2001 | CN1295474A Method for stabilizing pharmaceutical composition by special use of antioxidant |